A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor Xa Inhibitor

Grants and Contracts Details

StatusActive
Effective start/end date12/1/213/21/23

Funding

  • Portola Pharmaceuticals Inc.: $25,124.00